ArticlePloS one2018

Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer.

Yesim Gökmen-Polar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.